- Home
- RSI vs NVAX Comparison
RSI vs NVAX Comparison
Compare RSI & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RSI
- NVAX
- Stock Information
- Founded
- RSI 2012
- NVAX 1987
- Country
- RSI United States
- NVAX United States
- Employees
- RSI N/A
- NVAX N/A
- Industry
- RSI Services-Misc. Amusement & Recreation
- NVAX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RSI Consumer Discretionary
- NVAX Health Care
- Exchange
- RSI Nasdaq
- NVAX Nasdaq
- Market Cap
- RSI 1.3B
- NVAX 1.3B
- IPO Year
- RSI N/A
- NVAX 1995
- Fundamental
- Price
- RSI $18.56
- NVAX $8.37
- Analyst Decision
- RSI Strong Buy
- NVAX Buy
- Analyst Count
- RSI 9
- NVAX 6
- Target Price
- RSI $18.25
- NVAX $15.33
- AVG Volume (30 Days)
- RSI 2.0M
- NVAX 7.1M
- Earning Date
- RSI 07-30-2025
- NVAX 08-06-2025
- Dividend Yield
- RSI N/A
- NVAX N/A
- EPS Growth
- RSI N/A
- NVAX N/A
- EPS
- RSI 0.26
- NVAX 2.54
- Revenue
- RSI $1,017,900,000.00
- NVAX $1,078,718,000.00
- Revenue This Year
- RSI $15.47
- NVAX $52.02
- Revenue Next Year
- RSI $14.15
- NVAX N/A
- P/E Ratio
- RSI $71.09
- NVAX $3.29
- Revenue Growth
- RSI 26.99
- NVAX 9.22
- 52 Week Low
- RSI $8.76
- NVAX $5.01
- 52 Week High
- RSI $20.32
- NVAX $15.22
- Technical
- Relative Strength Index (RSI)
- RSI 65.08
- NVAX 65.20
- Support Level
- RSI $18.88
- NVAX $6.36
- Resistance Level
- RSI $19.79
- NVAX $8.46
- Average True Range (ATR)
- RSI 0.89
- NVAX 0.53
- MACD
- RSI 0.27
- NVAX 0.14
- Stochastic Oscillator
- RSI 70.32
- NVAX 72.83
About RSI Rush Street Interactive Inc.
Rush Street Interactive Inc is an online gaming and entertainment company that focuses on online casinos and online sports betting in the U.S. and Latin American markets. It provides customers with an array of gaming offerings such as real-money online casinos, online sports betting, and retail sports betting, as well as social gaming, which involves free-to-play games that use virtual credits that can be earned or purchased. The company generates revenue by offering online casinos, online sports betting, and social gaming directly to the end customer through its websites or apps. The company generates revenue through business-to-consumer (B2C) and business-to-business (B2B) models.
About NVAX Novavax Inc.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.